“Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study” (2021) Journal of Tropical Pharmacy and Chemistry, 5(4), pp. 347–352. doi:10.30872/j.trop.pharm.chem.v5i4.257.